POSEIDA THERAPEUTICS INC - Common Stock, par value $0.0001 per share (PSTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2020 to Q2 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
PSTX on Nasdaq
Shares outstanding
98,365,673
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of POSEIDA THERAPEUTICS INC - Common Stock, par value $0.0001 per share (PSTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$308,000 0
2025 Q1 100,000 $308,000 -$512,769,976 $3.08 1
2024 Q4 53,970,727 $518,070,752 +$17,008,807 $9.60 114
2024 Q3 53,512,171 $153,042,595 +$889,907 $2.86 94
2024 Q2 52,954,774 $154,591,146 -$128,086 $2.92 90
2024 Q1 52,747,602 $168,247,853 +$23,931,180 $3.19 90
2023 Q4 45,227,069 $151,964,876 +$388,861 $3.36 90
2023 Q3 45,211,925 $107,601,397 +$2,937,881 $2.38 85
2023 Q2 44,463,763 $78,239,697 -$5,736,756 $1.76 91
2023 Q1 44,145,641 $135,966,651 +$3,079,454 $3.08 101
2022 Q4 42,639,196 $225,970,611 +$18,484,174 $5.30 88
2022 Q3 40,082,757 $141,733,596 +$62,472,178 $3.53 66
2022 Q2 22,502,781 $58,056,750 -$5,315,127 $2.58 51
2022 Q1 24,182,970 $108,362,581 -$12,481,973 $4.48 62
2021 Q4 25,853,738 $176,062,275 -$2,997,826 $6.81 59
2021 Q3 26,151,081 $190,704,000 -$17,048,693 $7.29 62
2021 Q2 27,875,232 $279,302,000 -$10,459,200 $10.02 69
2021 Q1 28,928,358 $276,249,644 +$21,624,136 $9.55 62
2020 Q4 26,347,216 $288,434,000 +$15,183,869 $10.97 55
2020 Q3 25,108,950 $217,383,620 +$217,383,620 $8.87 51